RFCA
ARLZ

R&F Capital Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

R&F Capital Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$150K Buy
70,198
+56,567
+415% +$213K 0.04% 592
2016
Q4 		$60K Buy
+13,631
New +$64.7K 0.02% 468

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

R&F Capital Advisors's ARLZ Position: Q1 2017 in Review

R&F Capital Advisors increased its Aralez Pharmaceuticals Inc. (ARLZ) stake by 415% in Q1 2017, buying an estimated $213K and bringing the position to 70,198 shares worth $150K. The position accounts for 0.04% of the portfolio, ranked #592.

R&F Capital Advisors first reported a position in ARLZ in Q4 2016 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold ARLZ as of Q1 2017.

  • R&F Capital Advisors held 70,198 shares of Aralez Pharmaceuticals Inc. worth $150K as of Q1 2017.
  • R&F Capital Advisors bought 56,567 Aralez Pharmaceuticals Inc. shares in Q1 2017, an estimated $213K.
  • Aralez Pharmaceuticals Inc. made up 0.04% of R&F Capital Advisors's portfolio in Q1 2017, its #592 holding.
  • R&F Capital Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q4 2016 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.